Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 32

Cited In for PubMed (Select 11106782)

1.

Cannabinoid receptor 1 signaling in cardiovascular regulating nuclei in the brainstem: A review.

Ibrahim BM, Abdel-Rahman AA.

J Adv Res. 2014 Mar;5(2):137-45. doi: 10.1016/j.jare.2013.03.008. Epub 2013 Apr 3. Review.

2.

Role of Endocannabinoid Activation of Peripheral CB1 Receptors in the Regulation of Autoimmune Disease.

Sido JM, Nagarkatti PS, Nagarkatti M.

Int Rev Immunol. 2014 Jun 9. [Epub ahead of print]

PMID:
24911431
3.

Distinct roles of β-arrestin 1 and β-arrestin 2 in ORG27569-induced biased signaling and internalization of the cannabinoid receptor 1 (CB1).

Ahn KH, Mahmoud MM, Shim JY, Kendall DA.

J Biol Chem. 2013 Apr 5;288(14):9790-800. doi: 10.1074/jbc.M112.438804. Epub 2013 Feb 28.

4.

Marijuana dependence: not just smoke and mirrors.

Ramesh D, Schlosburg JE, Wiebelhaus JM, Lichtman AH.

ILAR J. 2011;52(3):295-308. doi: 10.1093/ilar.52.3.295.

5.

Endocannabinoids in neuroendopsychology: multiphasic control of mitochondrial function.

Nunn A, Guy G, Bell JD.

Philos Trans R Soc Lond B Biol Sci. 2012 Dec 5;367(1607):3342-52. doi: 10.1098/rstb.2011.0393. Review.

6.

Temporal changes in N-acylethanolamine content and metabolism throughout the peri-adolescent period.

Lee TT, Hill MN, Hillard CJ, Gorzalka BB.

Synapse. 2013 Jan;67(1):4-10. doi: 10.1002/syn.21609. Epub 2012 Oct 4.

7.

Identification and quantification of a new family of peptide endocannabinoids (Pepcans) showing negative allosteric modulation at CB1 receptors.

Bauer M, Chicca A, Tamborrini M, Eisen D, Lerner R, Lutz B, Poetz O, Pluschke G, Gertsch J.

J Biol Chem. 2012 Oct 26;287(44):36944-67. doi: 10.1074/jbc.M112.382481. Epub 2012 Sep 5.

8.

A brain on cannabinoids: the role of dopamine release in reward seeking.

Oleson EB, Cheer JF.

Cold Spring Harb Perspect Med. 2012 Aug 1;2(8). pii: a012229. doi: 10.1101/cshperspect.a012229. Review.

9.

MAPK14 and CNR1 gene variant interactions: effects on brain volume deficits in schizophrenia patients with marijuana misuse.

Onwuameze OE, Nam KW, Epping EA, Wassink TH, Ziebell S, Andreasen NC, Ho BC.

Psychol Med. 2013 Mar;43(3):619-31. doi: 10.1017/S0033291712001559. Epub 2012 Jul 31.

10.
11.

Endocannabinoids shape accumbal encoding of cue-motivated behavior via CB1 receptor activation in the ventral tegmentum.

Oleson EB, Beckert MV, Morra JT, Lansink CS, Cachope R, Abdullah RA, Loriaux AL, Schetters D, Pattij T, Roitman MF, Lichtman AH, Cheer JF.

Neuron. 2012 Jan 26;73(2):360-73. doi: 10.1016/j.neuron.2011.11.018.

12.

Blockade of endocannabinoid hydrolytic enzymes attenuates precipitated opioid withdrawal symptoms in mice.

Ramesh D, Ross GR, Schlosburg JE, Owens RA, Abdullah RA, Kinsey SG, Long JZ, Nomura DK, Sim-Selley LJ, Cravatt BF, Akbarali HI, Lichtman AH.

J Pharmacol Exp Ther. 2011 Oct;339(1):173-85. doi: 10.1124/jpet.111.181370. Epub 2011 Jun 30.

13.

Novel 1',1'-chain substituted hexahydrocannabinols: 9β-hydroxy-3-(1-hexyl-cyclobut-1-yl)-hexahydrocannabinol (AM2389) a highly potent cannabinoid receptor 1 (CB1) agonist.

Nikas SP, Alapafuja SO, Papanastasiou I, Paronis CA, Shukla VG, Papahatjis DP, Bowman AL, Halikhedkar A, Han X, Makriyannis A.

J Med Chem. 2010 Oct 14;53(19):6996-7010. doi: 10.1021/jm100641g.

14.

GPR55-dependent and -independent ion signalling in response to lysophosphatidylinositol in endothelial cells.

Bondarenko A, Waldeck-Weiermair M, Naghdi S, Poteser M, Malli R, Graier WF.

Br J Pharmacol. 2010 Sep;161(2):308-20. doi: 10.1111/j.1476-5381.2010.00744.x.

15.

Cannabinoid and cannabinoid-like receptors in microglia, astrocytes, and astrocytomas.

Stella N.

Glia. 2010 Jul;58(9):1017-30. doi: 10.1002/glia.20983. Review.

16.

The endocannabinoid system and pain.

Guindon J, Hohmann AG.

CNS Neurol Disord Drug Targets. 2009 Dec;8(6):403-21. Review.

17.

Signaling pathways from cannabinoid receptor-1 activation to inhibition of N-methyl-D-aspartic acid mediated calcium influx and neurotoxicity in dorsal root ganglion neurons.

Liu Q, Bhat M, Bowen WD, Cheng J.

J Pharmacol Exp Ther. 2009 Dec;331(3):1062-70. doi: 10.1124/jpet.109.156216. Epub 2009 Sep 14.

18.

Novel endogenous peptide agonists of cannabinoid receptors.

Gomes I, Grushko JS, Golebiewska U, Hoogendoorn S, Gupta A, Heimann AS, Ferro ES, Scarlata S, Fricker LD, Devi LA.

FASEB J. 2009 Sep;23(9):3020-9. doi: 10.1096/fj.09-132142. Epub 2009 Apr 20.

19.

The therapeutic potential of novel cannabinoid receptors.

Kreitzer FR, Stella N.

Pharmacol Ther. 2009 May;122(2):83-96. doi: 10.1016/j.pharmthera.2009.01.005. Epub 2009 Feb 25. Review.

20.

Cannabinoids, endocannabinoids, and related analogs in inflammation.

Burstein SH, Zurier RB.

AAPS J. 2009 Mar;11(1):109-19. doi: 10.1208/s12248-009-9084-5. Epub 2009 Feb 6. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk